Approval · Notice of Compliance 2813 · 1998
ORGARAN: Notice of Compliance 2813
Issued December 16, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2813
- Date
- December 16, 1998
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph revisions
- Therapeutic class
- Anticoagulant/antithrombotic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORGARAN | Not yet assigned | — |
Medicinal ingredients
- DANAPAROID SODIUM 750 UNIT per ML